Sitagliptin and Glucagon Counterregulation

Clinical trial NCT02256189 · COMPLETED

Trial details

NCT number: NCT02256189
Sponsor: Lund University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2015-04-01
Primary completion: 2017-06-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.